Pharmacotherapy for Patients With Fibromyalgia
J Clin Psychiatry 2008;69(suppl 2):25-29
© Copyright 2017 Physicians Postgraduate Press, Inc.
Access to this article is available to valid users
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Register: If you do not have one already, register for a free account.
Fibromyalgia is a common and disabling syndrome. Despite research
detailing the efficacy of a variety of medicinal treatments, most notably,
tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors, and
α2δ ligands, there is still widespread, routine use of
agents that are mostly ineffective in treating the central nature of
fibromyalgic pain. This article discusses pharmacotherapeutic options for
fibromyalgia, including those with high-level evidence for efficacy,
moderate-level evidence, and little or no evidence for efficacy. The
importance of an integrated treatment approach that includes pharmacotherapy
and at least one, but preferably more, of the most effective nonmedicinal
treatment options available (e.g., education, aerobic exercise, and
cognitive-behavioral therapy) is also discussed.